Azalea Vision Secures €9 Million Series A Funding to Advance Smart Visual Platform Development

GHENT, Belgium—Azalea Vision, a HealthTech company pioneering the future of vision, today announced the first closing of its Series A funding round, securing 9 million euros out of an intended 15 million euros. The company also announced the appointment of Robert J. Dempsey as Chairman of the Board to lead strategic growth in Europe and the United States. Enrique Vega, CEO of Azalea Vision, commented, "The strong support from established investors in this landmark Series A funding round reaffirms their confidence in our medical device and our vision for the future of intelligent eye health." Azalea Vision's platform aims to transform how vision is managed and treated. By integrating advanced technologies such as artificial intelligence and machine learning, the company is developing tools that can detect and monitor eye diseases more effectively. This innovative approach not only promises to improve patient outcomes but also to streamline healthcare processes, making vision care more accessible and efficient. Dempsey's appointment brings a wealth of experience to Azalea Vision. With a distinguished career in the technology and healthcare sectors, he has played a pivotal role in several successful startups and corporate expansions. His expertise will be crucial in guiding Azalea Vision as it scales its operations and expands into new markets. “The addition of Robert Dempsey as Chairman marks a significant milestone for us,” said Vega. “His extensive background in strategic leadership and market expansion will be invaluable as we continue to innovate and grow.” The company plans to use the funds to accelerate the development and clinical trials of its intelligent vision platform. This includes expanding its research and development team, enhancing its AI capabilities, and ensuring regulatory compliance in both Europe and the United States. Additionally, the funding will support marketing efforts and the establishment of partnerships with leading healthcare providers and organizations. Azalea Vision's commitment to advancing eye health through technology aligns with growing global trends. With an aging population and increasing prevalence of eye diseases, the demand for smarter, more personalized vision care solutions is on the rise. By leveraging cutting-edge technology, Azalea Vision is well-positioned to meet these needs and make a meaningful impact in the field of ophthalmology. The official version of this announcement is in the original language. Translations are provided for the convenience of readers and should refer to the original text for legal validity.